NR3C2 and diabetes mellitus: Here, we sought to determine whether this pathological pathway contributes to GEnGlx damage in diabetes, hypothesizing that MR antagonism reduces MMP activity in diabetes, preserving the GEnGlx and limiting the development of albuminuria.